Barclays PLC

BCS remains in a Stage 2 advancing uptrend with active higher highs and higher lows continuation, but price is extended above rising EMAs and overbought, suggesting near-term momentum fatigue. The Value + EPS strategy favors deferred entries on pullbacks into the rising EMA support zone, so execution should be stalked until acceptance into the EMA support.

• ↑Q1 2026 ROTE of 14% up from 11.3% last year.
• ↑Net interest income grew 12% YoY, targeting >£13.5 bn in FY26.
• ↓Recorded £228 m securitized products impairment, part of £823 m Q1 charges.